Neuronetics ROA 2017-2019 | STIM
Current and historical return on assets (ROA) values for Neuronetics (STIM) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Neuronetics ROA for the three months ending June 30, 2019 was -22.43%.
|Neuronetics ROA - Return on Assets Historical Data
||TTM Net Income
||Return on Assets
||Medical Instruments Manufacturing
Neuronetics, Inc. is a commercial-stage medical device company. It focused on designing, developing, and marketing products for patients who suffer from psychiatric disorders. NeuroStar Advanced Therapy System(R), is the transcranial magnetic stimulation treatment for depressive disorder. Neuronetics, Inc. is based in Malvern, United States.